Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

UE2343 × Lymphoid × 90 days × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Follicular 1 Dementia 1 Alzheimer Disease 1

Interventions

Cyclophosphamide 140 Rituximab 138 venetoclax 80 Specimen Handling 74 Vincristine 71 fludarabine 65 Prednisone 64 Doxorubicin 64 Magnetic Resonance Spectroscopy 61 Biopsy 59 obinutuzumab 53 Lenalidomide 45 ibrutinib 41 Cytarabine 41 Methotrexate 38 Dexamethasone 38 fludarabine phosphate 34 zanubrutinib 33 acalabrutinib 33 CT-P10 33 Etoposide 32 blinatumomab 28 Bendamustine Hydrochloride 28 glofitamab 26 prednylidene 25 pembrolizumab 25 deltacortene 25 Gemcitabine 24 pirtobrutinib 21 polatuzumab vedotin 20

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06125951 2026-02-18

XanaMIA

Actinogen Medical

Phase 2/3 Active not recruiting

Alzheimer Disease, Dementia, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡